COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases
Open Access
- 31 March 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Abstract
Aim To describe the clinical characteristics and outcome of hospitalized COVID-19 patients with diabetic ketoacidosis (DKA). Methods We report eight cases of diabetic ketoacidosis in COVID-19 who presented to our institution in New Jersey, USA. COVID-19 was diagnosed by nasopharyngeal swab reverse transcription polymerase chain reaction (RT-PCR). The patients' electronic medical records were reviewed. Data on patients' age, sex, ethnicity, laboratory values, glycosylated hemoglobin level, oral antihyperglycemic agents (OHAs), insulin, and clinical outcomes were collected. Results The median age of the patient was 42.5 years, and seven were males and one was female. Out of eight patients, five had type 2 diabetes mellitus (DM), two had undiagnosed DM, and one had type 1 DM. Median value of initial glucose on presentation was 454 mg/dL. Median value of HbA1c on presentation was 11.4% and of anion gap was 26.5 mEq/L. Four patients had large ketonemia, one patient had moderate ketonemia, and three patients had small ketonemia. All the patients were started on standard treatment protocol for DKA with intravenous fluids and IV insulin infusion. Acute kidney injury (AKI) was seen in four patients, and one patient required renal replacement therapy. Out of eight patients, three required mechanical ventilation, and the same three patients died. Conclusion Our case series shows that COVID-19 infection can precipitate DKA in patients with known diabetes mellitus patients or as a first manifestation in undiagnosed DM patients; COVID-19 with DKA is associated with substantial mortality. Further studies are needed to characterize poor risk factors associated with mortality in these patients.Keywords
This publication has 15 references indexed in Scilit:
- Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre studyDiabetes Research and Clinical Practice, 2020
- Diabetic Ketoacidosis in COVID-19: Unique Concerns and ConsiderationsThe Journal of Clinical Endocrinology & Metabolism, 2020
- Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19New England Journal of Medicine, 2020
- A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 PandemicThe Journal of Clinical Endocrinology & Metabolism, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Diabetes is a risk factor for the progression and prognosis of COVID‐19Diabetes/Metabolism Research and Reviews, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Acute Hyperglycemic Crises with Coronavirus Disease-19: Case ReportsDiabetes & Metabolism Journal, 2020
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complicationsNature Reviews Endocrinology, 2017